ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

11,133Medicare Part D Prescriptions Filled, Including Refills
$2.23M Total Retail Price of All Prescriptions
1,317 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 1,006 662
SYNTHROID 800 627
METFORMIN HCL 720 401
LANTUS 665 463
JANUVIA 562 452
PEN NEEDLE 523 342
INSULIN SYRINGE 518 382
LANTUS SOLOSTAR 394 257
SIMVASTATIN 374 243
PRANDIN 371 317 10
HUMALOG 305 103
NOVOLOG 239 138
NOVOLOG MIX 70-30 FLEXPEN 219 154
GLIMEPIRIDE 214 174
LISINOPRIL 175 110
HUMALOG MIX 75-25 171 102
ALENDRONATE SODIUM 171 139
NOVOLOG FLEXPEN 167 123
ATORVASTATIN CALCIUM 156 104
ANDROGEL 153 91 S3
NOVOLOG MIX 70-30 133 112
HUMALOG MIX 50-50 126 98
VICTOZA 3-PAK 113 69
AMLODIPINE BESYLATE 109 72
ZETIA 107 60
QUINAPRIL HCL 101 77
HYDROCHLOROTHIAZIDE 94 79
EASY TOUCH 92 63
TRADJENTA 91 74
ACTOS 90 53
FENOFIBRATE 89 55
NATEGLINIDE 87 82
TESTOSTERONE CYPIONATE 84 33 S3
METHIMAZOLE 82 61
LEVEMIR FLEXPEN 82 63
SURE COMFORT 81 47
BYETTA 79 42
LOSARTAN POTASSIUM 70 40
DIOVAN 70 57
JANUMET 60 52
ACTONEL 59 57
LEVEMIR 57 23
CALCITRIOL 57 35
TRICOR 50 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.